Pharmaceutical Investment Oversight and Accountability Act requires annual reports on foreign investment in the U.S. pharmaceutical industry.

The Pharmaceutical Investment Oversight and Accountability Act mandates the Federal Trade Commission to submit an annual report to Congress and relevant agencies on foreign investment in the U.S. pharmaceutical industry. The report must assess the U.S. pharmaceutical industry's supply chain, the impact of concentration and foreign manufacturing reliance, and the effect of foreign investment on domestic drug production capacity and DNA sequencing or storage. The Federal Trade Commission is authorized to conduct necessary studies and must publish a summary of the report on its website.

Pharmaceutical Investment Oversight and Accountability Act requires annual reports on foreign investment in the U.S. pharmaceutical industry.

The Pharmaceutical Investment Oversight and Accountability Act mandates the Federal Trade Commission to submit an annual report to Congress and relevant agencies on foreign investment in the U.S. pharmaceutical industry. The report must assess the U.S. pharmaceutical industry's supply chain, the impact of concentration and foreign manufacturing reliance, and the effect of foreign investment on domestic drug production capacity and DNA sequencing or storage. The Federal Trade Commission is authorized to conduct necessary studies and must publish a summary of the report on its website.